Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

NCT04070378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Daratumumab Injection

Sponsor

Marc L Gordon, MD

Collaborators

[object Object]